Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Zyprexa
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zyprexa 10mg tablets
040201060BBACAC
|
Zyprexa | Olanzapine | Central Nervous System | 721 |
|
Zyprexa 5mg tablets
040201060BBAAAA
|
Zyprexa | Olanzapine | Central Nervous System | 607 |
|
Zyprexa 2.5mg tablets
040201060BBADAD
|
Zyprexa | Olanzapine | Central Nervous System | 570 |
|
Zyprexa 10mg Velotabs
040201060BBAFAF
|
Zyprexa | Olanzapine | Central Nervous System | 306 |
|
Zyprexa 5mg Velotabs
040201060BBAEAE
|
Zyprexa | Olanzapine | Central Nervous System | 288 |
|
Zyprexa 20mg Velotabs
040201060BBAJAP
|
Zyprexa | Olanzapine | Central Nervous System | 255 |
|
Zyprexa 20mg tablets
040201060BBAKAQ
|
Zyprexa | Olanzapine | Central Nervous System | 231 |
|
Zyprexa 7.5mg tablets
040201060BBABAB
|
Zyprexa | Olanzapine | Central Nervous System | 166 |
|
Zyprexa 15mg tablets
040201060BBAHAL
|
Zyprexa | Olanzapine | Central Nervous System | 147 |
|
Zyprexa 15mg Velotabs
040201060BBAGAK
|
Zyprexa | Olanzapine | Central Nervous System | 108 |
|
Zyprexa 10mg powder for solution for injection vials
040201060BBAIAN
|
Zyprexa | Olanzapine | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.